MedPath

CARGO Therapeutics

CARGO Therapeutics logo
🇺🇸United States
Ownership
Public
Established
2021-01-01
Employees
116
Market Cap
$768.9M
Website
http://cargo-tx.com
Introduction

Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Carlos, CA.

markets.ft.com
·

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

Recent cancer treatment advancements include a stage 4 breast cancer patient achieving complete remission through immunotherapy and a Scottish woman receiving a personalized mRNA cancer vaccine. Key players in these advancements include Oncolytics Biotech Inc., Cargo Therapeutics, Inc., Immuneering Corporation, RenovoRx, Inc., and Repare Therapeutics Inc. Oncolytics Biotech highlights 2024 achievements and prepares for 2025 with promising breast and GI cancer data.
globenewswire.com
·

CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

CARGO Therapeutics, Inc. (NASDAQ: CRGX) will participate in the 43rd Annual J.P. Morgan Healthcare Conference on January 13-16, 2025, in San Francisco. Gina Chapman, President and CEO, will present on January 13 at 10:30 a.m. PT. The presentation will be webcast live on CARGO’s website, with a replay available for 30 days.
biospace.com
·

CARGO Therapeutics to Participate in Upcoming November 2024 Investor Conferences

CARGO Therapeutics to participate in Jefferies London and Piper Sandler Healthcare conferences, featuring CEO Gina Chapman in fireside chats.
globenewswire.com
·

CARGO Therapeutics to Participate in Upcoming Investor Conferences

CARGO Therapeutics, Inc. (NASDAQ: CRGX) to participate in Jefferies London Healthcare Conference on Nov 20 and Piper Sandler 36th Annual Healthcare Conference on Dec 4. Live webcasts available on CARGO’s website.
© Copyright 2025. All Rights Reserved by MedPath